Media Relations
Helen Ljungdahl Round
President and CEO
info@acarix.com
+46 73 077 02 83
+1 267 809 1225
Please enter your information in the form for general inquiries or to contact sales.
Additional contact information is listed below.
Helen Ljungdahl Round
President and CEO
info@acarix.com
+46 73 077 02 83
+1 267 809 1225
Christian Lindholm
CFO
info@acarix.com
+46 705 118 333
You may be able to find the information you need amongst the frequently asked questions.
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based Coronary Artery Disease (CAD) rule-out.
The CE-mark approved and FDA De Novo cleared Acarix CADScor®System is for patients experiencing stable chest pain with suspected CAD and is designed to help reduce millions of unnecessary and costly diagnostic procedures.2 CADScor®System calculates a patient-specific CAD-score non-invasively in 10 minutes with at least 96% confidence (Negative Predictive Value).¹
Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX).